ProKidney (Nasdaq: PROK), a pioneer in the treatment of CKD through innovations in cellular therapy, was founded in 2015 after a decade of research. ProKidney’s lead product candidate, REACT™ (Renal Autologous Cell Therapy), is a first-of-its-kind, patented disease-modifying autologous cellular ther... Read more
Women In Bio - Engage. Educate. Empower.
1 follower
Spectrum Medical
1 follower
AABB
3 followers
REVOLUTION Medicines
19 followers
Mozarc Medical
4 followers
Krystal Biotech
8 followers
C4 Therapeutics
8 followers
Revvity
15 followers
Cambridge Healthtech Institute
1 follower
Dyne Therapeutics
6 followers
Sanderling Renal Services-USA LLC
1 follower
Grow Therapy
11 followers